Shukra Pharmaceuticals Ltd (524632) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524632 | NSE: | Pharmaceuticals & Drugs | Small Cap

Shukra Pharma Share Price

39.92 0.33 0.83%
as on 05-Dec'25 12:16

Shukra Pharmaceuticals Ltd (524632) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524632 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Shukra Pharma

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Shukra Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
144.96
Market Cap:
1,733.6 Cr.
52-wk low:
6
52-wk high:
44.3

Is Shukra Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Shukra Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Shukra Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 2.4%7.4%5.9%3.6%0.8%0.5%5.8%18.9%44.2%21.8%-
Value Creation
Index
-0.8-0.5-0.6-0.7-1.0-1.0-0.60.42.20.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4.85.15.35.711.911.220.558.874.632.635
Sales YoY Gr.-6.4%3.9%6%109.4%-5.5%83%187.1%26.8%-56.3%-
Adj EPS 0000-0000.10.40.20.3
YoY Gr.-0%0%0%-100%NANA400%320%-47.6%-
BVPS (₹) 0.50.50.50.50.50.50.51.61.31.41.5
Adj Net
Profit
0.50.50.50.5-00.10.84.418.59.612
Cash Flow from Ops. 2.7-0.30.80.31.20.583.2-5.27.9-
Debt/CF from Ops. 0-0.14.323.46.518.20.41.6-0.60.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 23.6%22.4%16.7%-56.3%
Adj EPS 30.5%NA122.4%-47.6%
BVPS13.3%23.1%38.7%9.1%
Share Price 62.6% 194.6% 262.2% 544.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.63.53.63-0.20.94.721.244.715.918.4
Op. Profit
Mgn %
24.528.530.229.11312.914.19.12639.134.6
Net Profit
Mgn %
10.49.89.98.2-0.31.23.77.524.929.433.7
Debt to
Equity
000.20.40.50.60.20.20.10.10
Working Cap
Days
392379467526334487277201233558365
Cash Conv.
Cycle
756431403913254-910111269

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Shukra Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 0.3 -
TTM Sales (₹ Cr.) 35.1 -
BVPS (₹.) 1.5 -
Reserves (₹ Cr.) 22 -
P/BV 26.34 -
PE 144.96 -
From the Market
52 Week Low / High (₹) 6.00 / 44.31
All Time Low / High (₹) 0.00 / 44.31
Market Cap (₹ Cr.) 1,734
Equity (₹ Cr.) 43.8
Face Value (₹) 1
Industry PE 40.7

Management X-Ray of Shukra Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Shukra Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Shukra Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales5556121120597533
Operating Expenses 4444101018535520
Manufacturing Costs0000220001
Material Costs2111331045448
Employee Cost 1112445455
Other Costs 1111113466
Operating Profit 112221351913
Operating Profit Margin (%) 24.5%28.5%30.2%29.1%13.0%12.9%14.1%9.1%26.0%39.1%
Other Income 0000000134
Interest 0000000001
Depreciation 0011112223
Exceptional Items -10-000-00000
Profit Before Tax 011100142013
Tax 01000-00014
Profit After Tax 011000141910
PAT Margin (%) 2.5%9.8%9.8%8.2%0.3%1.7%3.7%7.5%24.9%29.4%
Adjusted EPS (₹)0.00.00.00.00.00.00.00.30.40.2
Dividend Payout Ratio (%)0%16%15%17%0%0%10%4%6%5%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 14151515151616255863
Share Capital 222222241144
Reserves 13131314141415214719
Minority Interest0000000000
Debt00468103433
Long Term Debt00468103433
Short Term Debt0000000000
Trade Payables11236593479
Others Liabilities 3344457121012
Total Liabilities 17192428343635757887

Fixed Assets

Gross Block20212629323435404143
Accumulated Depreciation11111213141618192124
Net Fixed Assets 10101416171818202019
CWIP 2222222222
Investments 0000000000
Inventories00001243210
Trade Receivables1235810730259
Cash Equivalents 210001041012
Others Assets 3455544161935
Total Assets 17192428343635757887

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 3-0101183-58
PBT 011100142013
Adjustment 0011212222
Changes in Working Capital 2-1-1-1-1-15-3-26-4
Tax Paid -0-0-0-000-0-0-1-4
Cash Flow From Investing Activity -0-1-5-2-3-2-2-4-1-1
Capex -0-1-5-2-3-2-2-4-2-3
Net Investments -0-0-0-0-0-0-0000
Others 00-0-0000011
Cash Flow From Financing Activity -103222-7512-5
Net Proceeds from Shares 00000005140
Net Proceeds from Borrowing 000002-61-10
Interest Paid 000000-0-0-0-1
Dividend Paid 00-0-0000-0-0-4
Others -1042200-0-00
Net Cash Flow 1-1-00-00-0462

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.853.513.553.040.231.214.721.1644.715.9
ROCE (%)2.47.415.943.620.770.545.7918.8544.2421.8
Asset Turnover Ratio0.270.280.270.250.440.320.581.070.980.4
PAT to CFO Conversion(x)N/A-01N/AN/AN/A80.75-0.260.8
Working Capital Days
Receivable Days55121171228177289153117134186
Inventory Days67271511225050221369
Payable Days97245526872563762246170168370

Shukra Pharmaceuticals Ltd Stock News

Shukra Pharmaceuticals Ltd FAQs

The current trading price of Shukra Pharma on 05-Dec-2025 12:16 is ₹39.92.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Shukra Pharma stood at ₹1,733.6.
The latest P/E ratio of Shukra Pharma as of 04-Dec-2025 is 145.0.
The latest P/B ratio of Shukra Pharma as of 04-Dec-2025 is 26.34.
The 52-week high of Shukra Pharma is ₹44.31 and the 52-week low is ₹6.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shukra Pharma is ₹35.12 ( Cr.) .

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals is an ambitious organisation with a deep rooted focus on sustainability with its impressive range of solutions. The company is committed to deliver excellence across National & Global markets. It is a public limited organisation with globally acclaimed manufacturing facilities.

The company is strongly committed to its values that guide it - The Shukra Group in serving the needs of its stakeholders including customers, suppliers, employees and other interest groups by large. Shukra stands for uncompromising quality and efficiency to deliver proven solutions delivered by passionate and motivated team of individuals.

The company boasts fully integrated structure for manufacturing general formulations like Tablet, Capsules and small volume parenteral since 2017. Along with internationally accredited facilities it invests in people.

The company has embarked upon its ambitious journey in the field of Pharamaceutical (date of inception) with a fully integrated plant in Rakanpor in Kalol, Gandhinagar - Gujarat. Since then, there was no looking back, within a short span of (years) the company has come a long way in making its mark in the sector.

The company has now developed an internationally accredited Laboratory in Ahmedabad where each product and solutions are developed under stringent quality processes.

Business area of the company

The company is engaged in the business of manufacturing and trading of pharmaceuticals Products, laboratory testing.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×